Foci Pharmaceutical: In 2024, the net profit is 60.0698 million yuan, a year-on-year decrease of 10.60%

Foci Pharmaceutical announced that the operating revenue for 2024 is 980 million yuan, a year-on-year decrease of 15.73%; the net profit attributable to shareholders of the listed company is 60.0698 million yuan, a year-on-year decrease of 10.60%; the basic earnings per share is 0.1176 yuan/share, a year-on-year decrease of 10.64%. The company plans to distribute a cash dividend of 0.12 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve converted into share capital